G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
11 hedge funds and large institutions have $453K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
57% more funds holding
Funds holding: 7 → 11 (+4)
13% less capital invested
Capital invested by funds: $522K → $453K (-$69K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$140K |
| 2 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
+$80.3K |
| 3 |
VF
Virtu Financial
New York
|
+$76.2K |
| 4 |
IA
IFG Advisors
St. Louis,
Missouri
|
+$28K |
| 5 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$4.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$99.1K |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$41K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$21.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 5 |
JP Morgan Chase
New York
|
-$1.37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $149K | -$21.5K | -220 | -6% |
|
|
2
JP Morgan Chase
New York
| $76K | -$1.37K | -14 | -0.8% |
|
|
3
Citadel Advisors
Miami,
Florida
| $64K | +$140K | +1,434 | New |
|
|
TCM
4
Tradewinds Capital Management
Bellingham,
Washington
| $62K | +$80.3K | +821 | +144% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $49K | -$99.1K | -1,013 | -48% |
|
|
VF
6
Virtu Financial
New York
| $35K | +$76.2K | +779 | New |
|
|
IA
7
IFG Advisors
St. Louis,
Missouri
| $13K | +$28K | +286 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
HWM
9
HighMark Wealth Management
St. Paul,
Minnesota
| $2K | +$4.6K | +47 | New |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$2.84K | +29 | New |
|
|
SFI
11
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$41K | -708 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$12K | -200 | Closed |
|
13
Citigroup
New York
| – | +$98 | +1 | New |
|
GMVD Hedge Fund Activity: Q1 2022 in Review
11 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q1 2022, worth a combined $453K — down 13% from $522K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new GMVD positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $140K. The largest seller was Geode Capital Management, cutting an estimated $99.1K.
- 11 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q1 2022, up from 7 in Q4 2021.
- Funds reported $453K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q1 2022, down 13% quarter-over-quarter.
- 6 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q1 2022 and 2 closed out, a net change of +4 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q1 2022 was Citadel Advisors, an estimated $140K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q1 2022 was Geode Capital Management, an estimated $99.1K sold.
Based on aggregated 13F filings for Q1 2022.